No profile data available.
Iridex Corporation (IRIX) is a healthcare company in the targeted healthcare equipment industry, based in Mountain View, United States, with about 93 full-time employees.
It reported revenue of $52.68 million for fiscal year 2026, up 8.2% from fiscal year 2024, and net income of -$4.44 million. In Q2 2027 (the quarter ended June 30, 2026) revenue was $12.57 million. United States was its largest region in fiscal year 2025, with 44% of revenue. Its market capitalization was $15.63 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Iridex reported $52.68 million in revenue for fiscal year 2026, up 8.2% from $48.67 million in fiscal year 2024. In Q2 2027 revenue was $12.57 million.
United States: 44% of revenue by region in fiscal year 2025, followed by Europe, Middle East and Africa (27%).
$15.63 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Nexalin Technology, Inc. (NXL), Guided Therapeutics, Inc. (GTHP), Femasys Inc. (FEMY), SeaStar Medical Holding Corporation (ICU).